According to cBioportal [20,21], the most common genetic alteration in TIGAR is amplification, but even in the tumor types in which the TIGAR DNA sequence is most altered, that is, uterine carcinosarcoma, genomic alterations are found in only 7% of the patients. Here, TIGAR is linked to neoplasm.